Amid a difficult year for federal support of university research, researchers from one of the world’s leading biomedical research institutions gathered to cast their lot with private funders. The ...
Summit Therapeutics (NASDAQ:SMMT) gains market attention as brokerage coverage expands across biotechnology discussions on ...
As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ — As Demy-Colton ...
With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results